Nyxoah SA - 4 Year Stock Price History | NYXH
- The all-time high Nyxoah SA stock closing price was 37.00 on August 06, 2021.
- The Nyxoah SA 52-week high stock price is 12.21, which is 96.9% above the current share price.
- The Nyxoah SA 52-week low stock price is 5.55, which is 10.5% below the current share price.
- The average Nyxoah SA stock price for the last 52 weeks is 8.69.
Nyxoah SA Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 8.9272 | 9.0400 | 11.4700 | 5.7100 | 6.2000 | -22.50% |
2024 | 9.4615 | 4.7250 | 19.5000 | 4.0300 | 8.0000 | 72.41% |
2023 | 6.7646 | 5.2900 | 10.3400 | 4.3700 | 4.6400 | -7.01% |
2022 | 12.2569 | 22.0000 | 23.0490 | 4.8000 | 4.9900 | -78.30% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.215B | $0.005B |
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $38.774B | 53.56 |
Hims & Hers Health (HIMS) | United States | $11.630B | 121.74 |
Tempus AI (TEM) | United States | $10.119B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.616B | 72.12 |
IRhythm Technologies (IRTC) | United States | $4.348B | 0.00 |
Privia Health (PRVA) | United States | $2.829B | 212.00 |
Enovis (ENOV) | United States | $1.955B | 12.10 |
Clover Health Investments (CLOV) | United States | $1.926B | 0.00 |
Schrodinger (SDGR) | United States | $1.732B | 0.00 |
Phreesia (PHR) | United States | $1.434B | 0.00 |
Azenta (AZTA) | United States | $1.154B | 53.74 |
Omnicell (OMCL) | United States | $1.154B | 20.35 |
10x Genomics (TXG) | United States | $1.016B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
Butterfly Network (BFLY) | United States | $0.530B | 0.00 |
Talkspace (TALK) | United States | $0.512B | 152.00 |
Veradigm (MDRX) | United States | $0.466B | 0.00 |
Standard BioTools (LAB) | United States | $0.387B | 0.00 |
TruBridge (TBRG) | United States | $0.381B | 850.00 |
Claritev (CTEV) | United States | $0.344B | 0.00 |
Health Catalyst (HCAT) | United States | $0.279B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
Pulmonx (LUNG) | United States | $0.148B | 0.00 |
American Well (AMWL) | United States | $0.106B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
CareCloud (CCLD) | United States | $0.080B | 3.03 |
111 (YI) | China | $0.064B | 0.00 |
HeartBeam (BEAT) | United States | $0.063B | 0.00 |
P3 Health Partners (PIII) | United States | $0.062B | 0.00 |
Outset Medical (OM) | United States | $0.042B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
Zhongchao (ZCMD) | China | $0.030B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |